Yang et al. showed that the miR-130b downregulation promoted the development of multidrug resistant ovarian cancer partially by targeting the 3′-UTR of CSF-1, while miR-130b silencing might be mediated by DNA methylation [32]. This evidence concerns the gene CSF1 and ovarian carcinoma.